LEDS [SemiLEDs] 8-K: (Original Filing)

[May 31, 2011 100 F Street, N.E. Re: SemiLEDs Corporation We were previously principal accountants for SemiLEDs Corporation and, under the date of October 26, 2010, except for the amendment to the preferred stock automatic conversion provisions discussed in Note 15, for which the date is November 20, 2010, and except for the effect of the reverse stock split described] []

By | 2016-04-03T06:31:52+00:00 May 31st, 2011|Categories: Chinese Stocks, LEDS, SEC Original|Tags: , , , , , |0 Comments

LEDS [SemiLEDs] 8-K: May 31, 2011 100 F Street, N.E. Re:

[May 31, 2011 100 F Street, N.E. Re: SemiLEDs Corporation We were previously principal accountants for SemiLEDs Corporation and, under the date of October 26, 2010, except for the amendment to the preferred stock automatic conversion provisions discussed in Note 15, for which the date is November 20, 2010, and except for the effect of the reverse stock split described] []

By | 2016-04-03T06:33:02+00:00 May 31st, 2011|Categories: Chinese Stocks, LEDS, Webplus ver|Tags: , , , , , |0 Comments

CBAK [CHINA BAK BATTERY] 8-K: (Original Filing)

[EMPLOYMENT AGREEMENT Agreement” Employee” RECITALS A. The Company has appointed the Employee as its Chief Financial Officer and the Employee has accepted such appointment for the term of Employment (as defined below). B. In connection with such appointment, the Company and the Employee desire to enter into this Agreement setting forth the terms and conditions of the Employment. AGREEMENT 1.]

CBAK [CHINA BAK BATTERY] 8-K: EMPLOYMENT AGREEMENT Agreement” Employee” RECITALS A. The Company

[EMPLOYMENT AGREEMENT Agreement” Employee” RECITALS A. The Company has appointed the Employee as its Chief Financial Officer and the Employee has accepted such appointment for the term of Employment (as defined below). B. In connection with such appointment, the Company and the Employee desire to enter into this Agreement setting forth the terms and conditions of the Employment. AGREEMENT 1.]

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts 10b5-1 Share Repurchase Plan Rule 10b5-1 permits corporate officers, directors and others to adopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These plans allow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-03-03T12:45:16+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts

[Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts 10b5-1 Share Repurchase Plan Rule 10b5-1 permits corporate officers, directors and others to adopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These plans allow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-03-03T12:46:25+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Chairman and CEO of Biostar Pharmaceuticals,opts 10b5-1 Share Repurchase Plan Rule 10b5-1 permitsrporate officers, directors and others toopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These planslow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-02-07T16:11:59+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Chairman and CEO of Biostar Pharmaceuticals,opts 10b5-1 Share

[Chairman and CEO of Biostar Pharmaceuticals,opts 10b5-1 Share Repurchase Plan Rule 10b5-1 permitsrporate officers, directors and others toopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These planslow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-02-07T16:12:50+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million “ ” “ ” XI’AN, CHINA – May 23, 2011 -- Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ( First Quarter 2011 Highlights · Revenue increases 46% YoY to $7.0 million · Veterinary vaccines]

By | 2016-03-01T05:18:01+00:00 May 24th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million “ ” “ ” XI’AN, CHINA – May 23, 2011 -- Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ( First Quarter 2011 Highlights · Revenue increases 46% YoY to $7.0 million · Veterinary vaccines]

By | 2016-03-01T05:18:40+00:00 May 24th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar